Wyndham CEO Geoff Ballotti discloses cancer treatment; CAO Rossi to depart July 31
Wyndham CEO Geoff Ballotti told team members on May 18, 2026 that he is undergoing treatment for multiple myeloma and plans to keep working largely as normal, with less travel. Chief Accounting Officer Nicola Rossi will leave on July 31, 2026, and Controller Christopher Androski will become Chief Accounting Officer on that date. At the May 14 annual meeting, stockholders re-elected all nine directors and approved a stockholder proposal on written consent.
Key points
- Ballotti's May 18 message (Exhibit 99.1) says he was diagnosed last week and began treatment at Beth Israel/Dana-Farber in Boston
- Rossi continues as Chief Accounting Officer until July 31, 2026; Androski, 52, is Senior Vice President and Controller and will succeed him
- All nine director nominees were elected at the May 14, 2026 annual meeting; say-on-pay passed with 54,328,340 votes for and 9,548,555 against
- Stockholders approved the written-consent proposal with 40,181,784 votes for and 23,709,518 against
The filing
Written by AI on Nov 8, 2026, 1:05 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 18, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.